Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.21
-0.11-3.31%
At close: -
$3.30
0.092.80%
After Hours: Jul 18, 9:16 AM EDT
Comments
Loading...
Larimar Therapeutics Stock Price, Quotes and Forecasts
LRMRNASDAQ
Larimar Therapeutics (LRMR) Forecast
NewsEarningsLarimar Therapeutics (LRMR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Larimar Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LRMR | Benzinga
Explore Larimar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LRMR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Larimar Therapeutics (LRMR) stock?
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Who are Larimar Therapeutics (LRMR) competitors?
Other companies in Larimar Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Tevogen Bio Holdings (NASDAQ:TVGN) and Eledon Pharmaceuticals (NASDAQ:ELDN).
What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?
Larimar Therapeutics has a consensus price target of $18.90.
What is the current price for Larimar Therapeutics (LRMR)?
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $3.3 last updated July 18, 2025 at 9:16 AM EDT.
Does Larimar Therapeutics (LRMR) pay a dividend?
There are no upcoming dividends for Larimar Therapeutics.
When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?
Larimar Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.
Is Larimar Therapeutics (LRMR) going to split?
There is no upcoming split for Larimar Therapeutics.
What sector and industry does Larimar Therapeutics (LRMR) operate in?
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
